Search bioRxiv⌕ Search

Biology subjects

Parida, P.

Publications and source records attributed to Parida, P..

3 recordsLinked to original sources

Hyperactivity preferentially disrupts scotopic retinal circuits in the early stages of diabetic retinopathy

Diabetic retinopathy is a leading cause of blindness worldwide. In this disease, visual impairments result from neurovascular dysfunction in the retina. However, the specific retinal circuits and the mechanisms underlying their dysfunction remain unclear. Here, in mouse models of diabetes, we evaluated scotopic (night vision) and photopic (day vision) retinal circuit function in the early stages of the disease. Using a combination of immunohistochemical, behavioral and electrophysiological techniques, we show that vision impairments early in the disease are not associated with widespread degeneration of the retinal circuitry but with abnormalities localized to scotopic circuits. Specifically, we observed swelling of axon terminals in rod but not cone bipolar cells. Importantly, these abnormalities were closely linked with bipolar cell activity, as rod bipolar cells showed higher intrinsic activity than cone bipolar cells, and inducing hyperactivity in control retinas was sufficient to recapitulate the pathology in diabetic rod bipolar cells. Further, the swollen rod bipolar cell terminals exhibited an increase in oxidative stress, consistent with cellular dysfunction. In line with this notion, electrophysiological measurements demonstrated that the contrast sensitivity of retinal ganglion cells was preferentially attenuated under scotopic conditions. Finally, behavioral experiments showed that visual sensitivity under scotopic conditions was affected earlier in disease progression compared to photopic conditions. Together, these findings reveal that scotopic circuits are preferentially affected in the early stages of diabetic retinopathy and that hyperactivity is sufficient to drive these abnormalities.

neuroscience↗

Novel nanopore sequencing method for determining Human Papillomavirus integrations in tumors without the need for whole genome sequencing

Human papillomaviral (HPV) integrations into host human genome, a key event in cervical carcinogenesis, are currently mapped through laborious and expensive sequencing methodologies. We developed and validated a novel library preparation strategy for nanopore sequencing to generate long targeted reads with HPV and human chimeric sequences. Using this strategy, we validated known HPV integrations in HeLa (HPV18) and SiHa (HPV16) cell lines. We also mapped integration sites in five HPV+ cervical cancer patients, which were confirmed by whole genome and Sanger sequencing. Our nanopore-based method provides a precise and efficient strategy to capture HPV integrations crucial for understanding tumorigenesis.

genomics↗

WNK1 Enhances Migration and Invasion in Breast Cancer Models

Metastasis is the major cause of mortality in breast cancer patients. Many signaling pathways have been linked to cancer invasiveness, but blockade of few protein components has succeeded in reducing metastasis. Thus, identification of proteins contributing to invasion that are manipulable by small molecules may be valuable in inhibiting spread of the disease. The protein kinase WNK1 (with no lysine (K) 1) has been suggested to induce migration of cells representing a range of cancer types. Analyses of mouse models and patient data have implicated WNK1 as one of a handful of genes uniquely linked to invasive breast cancer. Here we present evidence that inhibition of WNK1 slows breast cancer metastasis. We show that depletion or inhibition of WNK1 reduces migration of several breast cancer cell lines in wound healing assays and decreases invasion in collagen matrices. Furthermore, WNK1 depletion suppresses expression of AXL, a tyrosine kinase implicated in metastasis. Finally, we demonstrate that WNK inhibition in mice attenuates tumor progression and metastatic burden. These data showing reduced migration, invasion, and metastasis upon WNK1 depletion in multiple breast cancer models suggest that WNK1 contributes to the metastatic phenotype and that WNK1 inhibition may offer a therapeutic avenue for attenuating progression of invasive breast cancers.

cancer biology↗